Treatment of pelvic nerve dysfunction with a short course of pudendal nerve blocks and nsaids: a 4-year quality assurance review

Abstract

Chronic pelvic pain (CPP) affects approximately 15% of women and is often difficult to treat.1 Most women with CPP have symptoms suggestive of multi-organ system involvement including gynecologic, gastrointestinal, urologic, and musculoskeletal causes with or without central nervous system sensitization. Musculoskeletal origin pelvic pain has been reported to be associated with 22% of women with CPP.2 It is described by many names, but a common finding is abnormal sensitivity of tissues in the distribution of the pudendal nerve.